Founder Stack

Omnichannel diagnostics provider Redcliffe Labs has acquired Pune-based Megavision Diagnostics Center for approximately Rs 40 crore. The acquisition will help Redcliffe expand its integrated diagnostics offering by combining imaging and pathology services under a single platform. Megavision Diagnostics operates two MRI-equipped centres in Pune, adding advanced imaging capabilities to Redcliffe’s existing pathology network. The company said the acquisition will enable patients to access a wider range of diagnostic services through its network. Redcliffe will retain Megavision’s entire workforce as part of the transaction. The company said the move will ensure continuity of patient care while expanding access to diagnostic services in the region. The acquisition is part of Redcliffe’s strategy of expanding its diagnostics network through partnerships and acquisitions across key markets. Over the past year, the company acquired Prime Sonography & Diagnostic Center in Kota and Sarvodaya Diagnostics in Ajmer. Both now operate under Redcliffe Medicentre Imaging & Labs. Redcliffe said it has served more than 1 crore customers to date and operates across over 220 cities through more than 80 owned laboratories, with coverage across over 4,000 pincodes. The company offers more than 3,600 diagnostic tests. The acquisition comes amid a rise in consolidation in India’s diagnostics sector in 2026, as established diagnostic chains and genomics-focused companies use acquisitions to expand their geographic presence and add new capabilities. In May, Dr Lal PathLabs acquired 100% of Mumbai-based Shahbazkers Diagnostic Centre for up to Rs 20 crore, expanding its presence in Maharashtra. During the same month, MedGenome acquired a majority stake in Mumbai-based Siddhi Diagnostics & Research Centre (SDRC). Neuberg Diagnostics also acquired a controlling stake in Mumbai-based NM Medical, adding its network of 18 centres across Mumbai, Pune and Bengaluru. The deal expanded Neuberg’s presence across pathology, radiology and cardiology as the company prepares for a planned IPO. The recent deals reflect a shift in India’s diagnostics market toward integrated platforms that combine pathology, radiology, imaging, genomics and preventive healthcare. Larger diagnostic players are also using acquisitions to expand their presence across Tier-2 and Tier-3 markets. Bareback Media has recently raised funding from a group of investors. Some of the investors may directly or indirectly be involved in a competing business or might be associated with other companies we might write about. This shall, however, not influence our reporting or coverage in any manner whatsoever. You may find a list of our investorshere.